Bluensomycin
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281601This classification denotes an aminoglycoside antibiotic with the molecular formula C21H39N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LWV7PWE57U, chemically known as d-scyllo-inositol, o-2-deoxy-2-(methylamino)-alpha-l-glucopyranosyl-(1=>2)-o-5-deoxy-3-c-(hydroxymethyl)-alpha-l-lyxofuranosyl-(1=>2)-1-((aminoiminomethyl)amino)-1-deoxy-, 5-carbamate but generally known as bluensomycin, which bears US NIH Compound Identifier 65603. Bluensomycin most often comes in base and sulfate forms. The term BLUENSOMYCIN is an International Non-Proprietary Name. BLUENSOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bluensomycin under HS 29412080 and SITC 54132. As of Q4 2014, BLUENSOMYCIN remains the US FDA Preferred Term for this commodity. Bluensomycin bears US NLM identifiers UMLS ID C0053859 and NCI Concept Code C90636. SMILES: CC1C(C(C(O1)OC2C(C(C(C(C2O)O)OC(=O)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(CO)O.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.